questionsmedicales.fr
Actions chimiques et utilisations
Utilisations spécialisées de produits chimiques
Agents séquestrants
Agents séquestrants : Questions médicales fréquentes
Termes MeSH sélectionnés :
RNA Processing, Post-Transcriptional
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Agents séquestrants : Questions médicales les plus fréquentes",
"headline": "Agents séquestrants : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Agents séquestrants : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-03",
"dateModified": "2025-04-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Agents séquestrants"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Utilisations spécialisées de produits chimiques",
"url": "https://questionsmedicales.fr/mesh/D020313",
"about": {
"@type": "MedicalCondition",
"name": "Utilisations spécialisées de produits chimiques",
"code": {
"@type": "MedicalCode",
"code": "D020313",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chélateurs",
"alternateName": "Chelating Agents",
"url": "https://questionsmedicales.fr/mesh/D002614",
"about": {
"@type": "MedicalCondition",
"name": "Chélateurs",
"code": {
"@type": "MedicalCode",
"code": "D002614",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.832.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Agents chélateurs du calcium",
"alternateName": "Calcium Chelating Agents",
"url": "https://questionsmedicales.fr/mesh/D065096",
"about": {
"@type": "MedicalCondition",
"name": "Agents chélateurs du calcium",
"code": {
"@type": "MedicalCode",
"code": "D065096",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.832.500.204"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Agents chélateurs du fer",
"alternateName": "Iron Chelating Agents",
"url": "https://questionsmedicales.fr/mesh/D007502",
"about": {
"@type": "MedicalCondition",
"name": "Agents chélateurs du fer",
"code": {
"@type": "MedicalCode",
"code": "D007502",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.832.500.410"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Sidérophores",
"alternateName": "Siderophores",
"url": "https://questionsmedicales.fr/mesh/D017262",
"about": {
"@type": "MedicalCondition",
"name": "Sidérophores",
"code": {
"@type": "MedicalCode",
"code": "D017262",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.832.500.410.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Sidérophores",
"alternateName": "Siderophores",
"url": "https://questionsmedicales.fr/mesh/D017262",
"about": {
"@type": "MedicalCondition",
"name": "Sidérophores",
"code": {
"@type": "MedicalCode",
"code": "D017262",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.832.500.410.750"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Agents séquestrants",
"alternateName": "Sequestering Agents",
"code": {
"@type": "MedicalCode",
"code": "D064449",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Xueli Cao",
"url": "https://questionsmedicales.fr/author/Xueli%20Cao",
"affiliation": {
"@type": "Organization",
"name": "Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China."
}
},
{
"@type": "Person",
"name": "Yu Xiao",
"url": "https://questionsmedicales.fr/author/Yu%20Xiao",
"affiliation": {
"@type": "Organization",
"name": "Ministry of Education Key Laboratory of Protein Science, Beijing Advanced Innovation Center for Structural Biology, Beijing Frontier Research Center for Biological Structure, School of Life Sciences, Tsinghua University, Tsinghua-Peking Center for Life Sciences, Beijing 100084, China."
}
},
{
"@type": "Person",
"name": "Erin Huiting",
"url": "https://questionsmedicales.fr/author/Erin%20Huiting",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94158, USA."
}
},
{
"@type": "Person",
"name": "Dong Li",
"url": "https://questionsmedicales.fr/author/Dong%20Li",
"affiliation": {
"@type": "Organization",
"name": "Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China."
}
},
{
"@type": "Person",
"name": "Jie Ren",
"url": "https://questionsmedicales.fr/author/Jie%20Ren",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory for Biology of Plant Diseases and Insect Pests, Ministry of Agriculture, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing 100081, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Brix protein APPAN plays a role in ribosomal RNA processing in Arabidopsis.",
"datePublished": "2023-05-03",
"url": "https://questionsmedicales.fr/article/37146691",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.plantsci.2023.111721"
}
},
{
"@type": "ScholarlyArticle",
"name": "Suppression of multiple phenotypic and RNA processing defects by overexpression of oligoribonuclease in Escherichia coli.",
"datePublished": "2023-03-02",
"url": "https://questionsmedicales.fr/article/36870683",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jbc.2023.104567"
}
},
{
"@type": "ScholarlyArticle",
"name": "Structural and mechanistic basis of RNA processing by protein-only ribonuclease P enzymes.",
"datePublished": "2022-06-18",
"url": "https://questionsmedicales.fr/article/35725940",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.tibs.2022.05.006"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dynamic landscape of m6A modifications and related post-transcriptional events in muscle-invasive bladder cancer.",
"datePublished": "2024-10-08",
"url": "https://questionsmedicales.fr/article/39380003",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12967-024-05701-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Selective RNA Processing and Stabilization are Multi-Layer and Stoichiometric Regulators of Gene Expression in Escherichia coli.",
"datePublished": "2023-10-16",
"url": "https://questionsmedicales.fr/article/37845007",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/advs.202301459"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Actions chimiques et utilisations",
"item": "https://questionsmedicales.fr/mesh/D020164"
},
{
"@type": "ListItem",
"position": 3,
"name": "Utilisations spécialisées de produits chimiques",
"item": "https://questionsmedicales.fr/mesh/D020313"
},
{
"@type": "ListItem",
"position": 4,
"name": "Agents séquestrants",
"item": "https://questionsmedicales.fr/mesh/D064449"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Agents séquestrants - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Agents séquestrants",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-04-30",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Agents séquestrants",
"description": "Comment diagnostiquer une intoxication aux métaux lourds ?\nQuels examens pour évaluer l'efficacité d'un agent séquestrant ?\nQuels symptômes indiquent un besoin d'agents séquestrants ?\nComment identifier une carence nutritionnelle ?\nQuels signes d'overdose d'agents séquestrants ?",
"url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=RNA+Processing,+Post-Transcriptional&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Agents séquestrants",
"description": "Quels symptômes d'une carence en fer ?\nComment reconnaître une toxicité au plomb ?\nQuels signes d'une carence en calcium ?\nQuels symptômes d'une intoxication au mercure ?\nComment se manifeste une carence en potassium ?",
"url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=RNA+Processing,+Post-Transcriptional&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Agents séquestrants",
"description": "Comment prévenir les carences nutritionnelles ?\nQuelles mesures pour éviter l'exposition aux métaux lourds ?\nComment réduire le cholestérol par l'alimentation ?\nQuels aliments riches en calcium pour la prévention ?\nComment éviter les effets secondaires des séquestrants ?",
"url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=RNA+Processing,+Post-Transcriptional&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Agents séquestrants",
"description": "Quels agents séquestrants pour le cholestérol ?\nComment fonctionnent les agents séquestrants ?\nQuels sont les effets secondaires des agents séquestrants ?\nComment administrer un agent séquestrant ?\nQuels agents séquestrants pour les métaux lourds ?",
"url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=RNA+Processing,+Post-Transcriptional&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Agents séquestrants",
"description": "Quelles complications d'une surconsommation d'agents séquestrants ?\nQuels risques d'une utilisation prolongée ?\nComment les agents séquestrants affectent-ils l'absorption des médicaments ?\nQuelles complications liées à l'intoxication au plomb ?\nQuels effets à long terme des agents séquestrants ?",
"url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=RNA+Processing,+Post-Transcriptional&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Agents séquestrants",
"description": "Quels facteurs augmentent le risque de carences ?\nQui est à risque d'intoxication au mercure ?\nQuels groupes sont vulnérables aux carences en calcium ?\nQuels comportements augmentent le risque d'intoxication aux métaux ?\nQuels facteurs influencent l'absorption des nutriments ?",
"url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=RNA+Processing,+Post-Transcriptional&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux métaux lourds ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et urinaires peuvent détecter la présence de métaux lourds."
}
},
{
"@type": "Question",
"name": "Quels examens pour évaluer l'efficacité d'un agent séquestrant ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses biochimiques peuvent mesurer les niveaux de nutriments ou toxines."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin d'agents séquestrants ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des douleurs abdominales ou des troubles digestifs peuvent indiquer un besoin."
}
},
{
"@type": "Question",
"name": "Comment identifier une carence nutritionnelle ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins peuvent révéler des carences en vitamines ou minéraux."
}
},
{
"@type": "Question",
"name": "Quels signes d'overdose d'agents séquestrants ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des nausées, vomissements ou diarrhées peuvent signaler une overdose."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une carence en fer ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, pâleur, essoufflement et vertiges sont des symptômes courants."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une toxicité au plomb ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs abdominales, des troubles neurologiques et des anémies peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels signes d'une carence en calcium ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des crampes musculaires, des engourdissements et des troubles de l'humeur peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une intoxication au mercure ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tremblements, des troubles de la mémoire et des problèmes de vision peuvent se manifester."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une carence en potassium ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des faiblesses musculaires, des palpitations et des troubles du rythme cardiaque peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment prévenir les carences nutritionnelles ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et variée est essentielle pour éviter les carences."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter l'exposition aux métaux lourds ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les aliments contaminés et utiliser des filtres à eau peut réduire l'exposition."
}
},
{
"@type": "Question",
"name": "Comment réduire le cholestérol par l'alimentation ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consommer des fibres solubles et limiter les graisses saturées aide à réduire le cholestérol."
}
},
{
"@type": "Question",
"name": "Quels aliments riches en calcium pour la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les produits laitiers, les légumes verts et les noix sont de bonnes sources de calcium."
}
},
{
"@type": "Question",
"name": "Comment éviter les effets secondaires des séquestrants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Prendre les agents séquestrants avec suffisamment d'eau et suivre les recommandations médicales."
}
},
{
"@type": "Question",
"name": "Quels agents séquestrants pour le cholestérol ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les résines comme le cholestyramine sont utilisées pour réduire le cholestérol sanguin."
}
},
{
"@type": "Question",
"name": "Comment fonctionnent les agents séquestrants ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils se lient aux substances dans l'intestin, empêchant leur absorption dans le sang."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des agents séquestrants ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des effets comme des ballonnements, des nausées et des troubles digestifs peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment administrer un agent séquestrant ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont généralement pris par voie orale, souvent mélangés à des liquides."
}
},
{
"@type": "Question",
"name": "Quels agents séquestrants pour les métaux lourds ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des agents comme l'EDTA sont utilisés pour traiter les intoxications aux métaux lourds."
}
},
{
"@type": "Question",
"name": "Quelles complications d'une surconsommation d'agents séquestrants ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surconsommation peut entraîner des carences nutritionnelles et des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Quels risques d'une utilisation prolongée ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une utilisation prolongée peut causer des déséquilibres électrolytiques et des carences."
}
},
{
"@type": "Question",
"name": "Comment les agents séquestrants affectent-ils l'absorption des médicaments ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent réduire l'absorption de certains médicaments, diminuant leur efficacité."
}
},
{
"@type": "Question",
"name": "Quelles complications liées à l'intoxication au plomb ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques, rénales et cardiovasculaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels effets à long terme des agents séquestrants ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des effets à long terme peuvent inclure des carences nutritionnelles et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de carences ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation déséquilibrée, des maladies chroniques et des régimes restrictifs augmentent le risque."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'intoxication au mercure ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes consommant régulièrement des poissons contaminés sont à risque élevé."
}
},
{
"@type": "Question",
"name": "Quels groupes sont vulnérables aux carences en calcium ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées, les femmes enceintes et les végétariens peuvent être plus vulnérables."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque d'intoxication aux métaux ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Travailler dans des environnements contaminés ou utiliser des produits non réglementés augmente le risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs influencent l'absorption des nutriments ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, la santé digestive et les interactions médicamenteuses influencent l'absorption."
}
}
]
}
]
}
Arabidopsis APPAN is a Brix family protein that is homologous to yeast Ssf1/Ssf2 and PPan in higher eukaryotes. A previous study, mostly based on physiological experiments, revealed that APPAN plays a...
Oligoribonuclease (Orn) is an essential ribonuclease (RNase) from Escherichia coli (E. coli), which plays a critical role in the conversion of short RNA molecules (NanoRNAs) to mononucleotides. Althou...
Ribonuclease P (RNase P) enzymes are responsible for the 5' processing of tRNA precursors. In addition to the well-characterised ribozyme-based RNase P enzymes, an evolutionarily distinct group of pro...
Muscle-invasive bladder carcinoma (MIBC) is a serious and more advanced stage of bladder carcinoma. N6-Methyladenosine (m6A) is a dynamic and reversible modifications that primarily affects RNA stabil...
Paired tumor and adjacent-normal tissues were obtained from three patients with MIBC following radical cystectomy. The additional paired tissues for validation were obtained from patients underwent tr...
The prognostic-related m6A genes and m6A-risk model constructed by machine learning enables the stratification of high and low-risk patients with precision. A novel m6A modification site in the 3' unt...
The state-of-the-art Nanopore direct-RNA sequencing and machine learning techniques enables comprehensive identification of m6A modification and provided insights into the potential post-transcription...
Selective RNA processing and stabilization (SRPS) facilitates the differential expression of multiple genes in polycistronic operons. However, how the coordinated actions of SRPS-related enzymes affec...
The rixosome defined in Schizosaccharomyces pombe and humans performs diverse roles in pre-ribosomal RNA processing and gene silencing. Here, we isolate and describe the conserved rixosome from Chaeto...
The 14q32 locus is an imprinted region in the human genome which contains multiple non-coding RNAs. We investigated the role of the long non-coding RNA maternally expressed gene 8 (MEG8) in endothelia...
Breast cancer is the most common cancer type among women worldwide. The majority of breast cancer expresses estrogen receptor (ER) and endocrine therapy is a standard treatment of ER-positive breast c...
NAD can be inserted co-transcriptionally via non-canonical initiation to form NAD-RNA. However, that mechanism is unlikely for CoA-linked RNAs due to low intracellular concentration of the required in...
Co-expression of two or more genes at the single-cell level is usually associated with functional co-regulation. While mRNA co-expression-measured as the correlation in mRNA levels-can be influenced b...